0% found this document useful (0 votes)
5 views30 pages

Elephantiasis: Global Burden & Management

Uploaded by

nithishdino
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
5 views30 pages

Elephantiasis: Global Burden & Management

Uploaded by

nithishdino
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

INDEX STUDY ON ELEPHANTIASIS

1 Introduction 02
2 Identification 03
3 Infectious agent 06
4 Occurrence: global Burden 11
5 Periodicity 17
6 Reservoir 18
7 Environmental factor 19
8 Mode of transmission 20
9 Economical burden 22
10 Management 23
11 Method of control 24
 Lymph hati
tic filariiasiis,
fil commonlly known as
elephantiasis, is a neglected tropical disease.
 Infection is usually acqu acquired in childhood causing
g hidden
damage to the lymphatic system.
 The painful and profoundly disfiguring visible
manif ifesttati
tions off the
th
disease, lymphoedema, elephantiasis and scrotal
swelling g occur later in life and lead to permanent
disability.
 These patients are not only physically disabled, but
suffer
ff mental, social and financial losses
mental
contributing to stigma and poverty.
Clinical Manifestations:
Lymphatic Filariasis :-
a. Asymptomatic amicrofilaraemia
b. Asyptomatic Microfilaraemia - carriers
c. Acute recurrent filarial
fever, lymphadenitis, lymphenigitis, epididimoorchitis (♂)
d. Chronic manifestation – 10-15 yrs after acute attack, fibrosis -
hydrocoele, chyluria, elephantiasis of limbs, breast and
genitalia, permanent deformity.
Acute Dermatolymphangioadenitis
g swelling
Leg g

Recurrent “attacks”
attacks

Loss of wages

Unable to participate
i social
in i l functions
f ti
 Filariasis is caused by the nematode
worm, either Wuchereria bancrofti or Brugia malayi
 round, coiled and thread-like parasitic worms belonging to
the family filaridea.
 In India, 99.4% of the cases are caused by the species -
Wuchereria
W h i bancrofti
b fti whereas
h Brugia
B i malayi
l i is
i responsible
ibl for
f
0.6% of the problem.
Blood smear: Micofilaria

Blood smear
Concentration methods
Nuclepore filtration technique - advantages
Organism Vectors Disease produced
Wuchereria Culex Mosquitoes Lymphatic filariasis
bancrofti
Brugia malayi Mansonia Mosquitoes Lymphatic filariasis

Brugia timori Anopheles mosquitoes Lymphatic filariasis


Mansonia mosquitoes

Onchocerca Simulum flies Subcutaneous


volvulus ;
nodules;River
blindness
Mf.([Link])
( ) Mf.(B
( malayi)
y)
General Graceful, Sweeping Crinkled, secondary
Appearance curves curves

Length 244u to 296u 177u to 230u

Fee cephalic space As long as broad Nearly twice as long


as broad

Excretoryy pore
p Not p
prominent Prominent
 Currently,more than 1.4 billion people in 83 countries are at
risk of being infected.

 Approximately 80% of these people are living in 10


countries:
 Bangladesh, Democratic Republic of
Congo, Ethiopia, India, Indonesia, Myanmar, Nigeria, Nepal, Philippi
nes and the United Republic
public of Tanzania.
Countries with lymphatic filariasis

LF s tatus of c ountries as of May 2000

endemic

pos t-endemic or uncertain

non-endemic

W orld Health Organization


Global Programme for Elimination of Lymhatic Filariasis
 Globally,
an estimated 25 million men suffer with genital
disease and over 15 million people are afflicted with
lymphoedema.

 Eliminating lymphatic filariasis can prevent unnecessary


suff
fferiing and
d conttribut
ib te to th
the red
duction
ti off povertty (WHO
March 2014)
Affected Districts
 600 million are living in endemic areas

(450 in rural areas + 150 in urban areas)

 31 million microfilaria carriers

 23 million filaria disease cases

 India contributes 38% of LF problem in the world and


more than 70% in SEA Region

(2008 statistics)
 Filariiasis
Fil i has been a maj
major
jor public
bli health
h l h problem
probl
blem
bl iin
India next only to malaria.
 The disease was recorded in India as early as 6th
century B.C. by the famous Indian physician, Susruta in
his book Susruta Samhita.
 In 7th h century A.D., Madhavak
dh d
kara describ d signs and
bed d
symptoms of the disease in his treatise 'Madhava
Nidhana' which hold good even todayy.
 In 1709, Clarke called elephantoid legs in Cochin
as Malabar legs.
 The discovery of microfilariae (mf) in the peripheral
blood was made first by Lewis in 1872 in Calcutta
((Kolkata)
o ).
 Nocturnal periodicity
 10 pm – 2 am : Maximal density of Mf in blood
 Reversal of periodicity y
 Non-periodic: Mf detected through out the day In south
pacific islands and limited areas of Nicobar island, Thailand
and Vietnam
Animal Reservoir
 No -- W.b.
 Yes -- B.m. i.e. monk
key,catts,d
dogs
 Climate favoring vector
 Temperature :22-38 deg
 70% relative humidity
y
 Poor Drainage, poor sewage disposal, lack of town planning
 Common breeding g places:
p pool,, soakag
cessp p , ill
ge pits,
maintained drains, septic tanks, open ditches etc.
 Transmitted by the bite of infected vector mosquito
 These parasites after getting deposited on skin penetrate on
their own or through the opening created by mosquito bites
to reach the lymphatic system.
 Dynamics of transmission depends upon infective biting rate.
 Loss of human day ys
 Loss of productivity
 Loss of wages
 Annual loss to India US $
1.5 billion
 Cost for DEC
implementation Rs 1
 Total 5 yr investment US
12 million
 Less than 1% of burden
 Home based management
 Treatment for uncomplicated ADLA
 Antibiotic, analgesic and supportive measures
 No anti-filarial medicine.
 Treatment for complicated ADLA
 IV Antibiotics, analgesics, antipyretics
 No anti-filarial medicine.
 Hydrocele management: Surgery

ADLA: Acute Dermato Lymphangio Adenitis


 Chemotherapy
 Vector control
SPECIFIC TREATMENT

a. Individual

i) DEC – Diethyl Carbamazine – safe, effective

06mg/kg orally x 12 days

may produce toxic reactions

a. due to drugs

b. due to worms

better to give in spaced doses


b. Community Level:
i
i. Mass Therapy
Therapy- not recommended
ii. Selective treatment- 06 mg/kg x 12 days (2 wks)
to repeat after 02 yrs
- inadequate clearance
- reinfection
iii. DEC Medicated Salt : Mf Carriers only
01 04 gm DEC/kg x 06 – 09 m
01-04
Safe cheap and effective
iv)) Ivermectin - 20-400 ug
g / kg
g (weeks))
recurrance by 03m
geometric mean 06m.
g
Vector Control
- A til
Antilarval
l measures
.Chemical control
Removall off Pi
.R Pisti
tia plant
l t
.Minor environmental measures
- A ti dult
Antiad lt measures – nott very eff
ffecti
tive
- Personal prophylaxis

Public Education
Long term control
 WHO launched its Global Programme g to Eliminate Lymphatic
y p
Filariasis (GPELF) in 2000 with the aim of eliminating the disease
as a public-health problem. In 2012, the WHO NTD Roadmap
2020
reconfirmed the target date for achieving elimination by 2020.
 WHO’s strategy is based on 2 key components:
 stopping transmission through large scale annual treatment of all
large-scale
eligible people in an area or region where infection is present;
present;
 alleviating the suffering caused by lymphatic filariasis through
increased
i d morbidi
morbidity
bidi
bidity management and d didisability
bili prevention
i
activities
THANK YOU

Common questions

Powered by AI

Achieving global elimination of lymphatic filariasis by 2020, as targeted by the WHO, faces several challenges. These include high infection rates in endemic areas, difficulty in implementing mass drug administration effectively due to reinfection risks, and ensuring sustained vector control . Socioeconomic factors such as poverty and stigma also hinder access to healthcare and treatment compliance . Additionally, environmental conditions that favor mosquito breeding present ongoing hurdles to breaking transmission cycles . The need for comprehensive strategies addressing these multi-faceted issues remains critical .

Lymphatic filariasis has profound social and economic impacts, including physical disability due to lymphoedema and elephantiasis, resulting in loss of productivity and wages . The disfigurement and disability from the disease often lead to social stigma and exclusion, compounding the financial burdens on affected families . In India alone, the annual economic loss is estimated at US $1.5 billion, highlighting the significant impact on both individuals and broader communities .

Individual treatment strategies for lymphatic filariasis include DEC (Diethylcarbamazine) administration, which is effective but can cause toxic reactions if not given in spaced doses . For acute conditions like ADLA, supportive antibiotics are used without anti-filarial drugs . At the community level, mass therapy is generally not recommended due to the risk of reinfection and inadequate clearance of the parasite . Instead, selective treatment using DEC is promoted, and DEC medicated salt has been found safe and effective for carriers . Vector control and public education also play crucial roles in community-level management .

The global burden of lymphatic filariasis is primarily due to its widespread prevalence, affecting over 1.4 billion people in 83 countries . Contributing factors include the high infection rates in specific endemic regions, such as India, which accounts for 38% of global cases . Environmental factors like poor drainage and inadequate sewage systems further exacerbate the spread, as they create breeding grounds for vector mosquitoes . Socio-economic conditions also play a role, as the disease leads to significant physical disabilities, stigmatization, and economic losses .

Clinical manifestations of lymphatic filariasis range from asymptomatic stages to severe chronic conditions. Initially, individuals may have asymptomatic amicrofilaraemia or microfilaraemia, where they carry the parasite without symptoms but contribute to disease spread . Acute presentations include recurrent filarial fevers and lymphadenitis, while chronic conditions manifest as elephantiasis, lymphoedema, and hydrocele, severely impacting mobility and quality of life . These disfiguring effects lead to social stigma, mental distress, and economic losses due to decreased productivity and inability to participate in social functions . Comprehensive management is needed to address these severe quality of life impacts .

Climate and environmental conditions greatly influence the prevalence of lymphatic filariasis by affecting mosquito breeding habitats. Warm temperatures (22-38°C) and high humidity (70% relative) support vector mosquito populations . Poor drainage and inadequate waste management further create ideal breeding grounds in cesspools and soakage pits . These conditions facilitate mosquito proliferation, increasing the risk of disease transmission in affected regions .

The asymptomatic phase of lymphatic filariasis, particularly in amicrofilaraemic and microfilaraemic carriers, contributes significantly to the spread as individuals unknowingly harbor the parasite and facilitate transmission through mosquito bites . These carriers can perpetuate the life cycle of the disease without presenting noticeable symptoms, thereby allowing ongoing transmission within communities .

Historical perspectives on lymphatic filariasis in India reveal its recognition since the 6th century B.C. by physician Susruta, who documented the disease in the Susruta Samhita . In the 7th century A.D., Madhavakkara further described its signs and symptoms in 'Madhava Nidhana', with some still holding relevance today . The disease was notably characterized by Clarke in 1709 as 'Malabar legs' in Cochin . These historical accounts underscore the enduring challenge the disease poses and its significance in Indian medical history .

Vector control is crucial in the prevention and management of lymphatic filariasis as it targets the mosquito vectors that transmit the disease . Effective vector control involves anti-larval measures like chemical control and environmental management to eliminate mosquito breeding sites . While adult mosquito control measures are less effective, personal prophylaxis and public education enhance overall prevention efforts . Integration of these practices alongside treatment strategies is essential for reducing transmission rates and managing the disease sustainably .

The primary mode of transmission for lymphatic filariasis is through the bite of infected mosquitoes. Key mosquito vectors include Culex species, which transmit Wuchereria bancrofti, and Mansonia species, responsible for transmitting Brugia malayi . Anopheles mosquitoes also transmit Brugia timori . These vectors facilitate the parasitic worms’ entry into the human lymphatic system, sustaining the life cycle of the disease .

You might also like